Cargando…
Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 2—Treatment and Prognosis
Takotsubo syndrome (TTS) represents a form of acute heart failure featured by reversible left ventricular systolic dysfunction. The management during the acute phase is mainly performed with supportive pharmacological (diuretics, ACE-inhibitors/angiotensin-receptor blockers (ARBs), anticoagulants, a...
Autores principales: | Santoro, Francesco, Mallardi, Adriana, Leopizzi, Alessandra, Vitale, Enrica, Rawish, Elias, Stiermaier, Thomas, Eitel, Ingo, Brunetti, Natale D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866173/ https://www.ncbi.nlm.nih.gov/pubmed/33530545 http://dx.doi.org/10.3390/jcm10030468 |
Ejemplares similares
-
Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1—Pathophysiology and Diagnosis
por: Rawish, Elias, et al.
Publicado: (2021) -
Prognostic role of neoplastic markers in Takotsubo syndrome
por: Santoro, Francesco, et al.
Publicado: (2021) -
Takotsubo syndrome and cardiogenic shock: Authors' response
por: Santoro, Francesco, et al.
Publicado: (2023) -
Oral anticoagulation in high risk Takotsubo syndrome: when should it be considered and when not?
por: Santoro, Francesco, et al.
Publicado: (2018) -
Neutrophil/lymphocyte ratio predicts in‐hospital complications in Takotsubo syndrome. Results from a prospective multi‐center registry
por: Santoro, Francesco, et al.
Publicado: (2020)